Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea
· Delayed Price · Currency is KRW 91,700
+1,200 (1.33%)
At close: Dec 5, 2025
Curiox Biosystems Revenue
Curiox Biosystems had revenue of 1.38B KRW in the quarter ending September 30, 2025, with 45.53% growth. This brings the company's revenue in the last twelve months to 4.26B, down -28.63% year-over-year. In the year 2024, Curiox Biosystems had annual revenue of 4.59B, down -32.41%.
Revenue (ttm)
4.26B
Revenue Growth
-28.63%
P/S Ratio
367.95
Revenue / Employee
n/a
Employees
27
Market Cap
1,566.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.59B | -2.20B | -32.41% |
| Dec 31, 2023 | 6.79B | -449.07M | -6.21% |
| Dec 31, 2022 | 7.24B | 1.71B | 31.04% |
| Dec 31, 2021 | 5.52B | 1.14B | 25.97% |
| Dec 31, 2020 | 4.38B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |